SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 221 filers reported holding SORRENTO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $80,585 | +41.4% | 90,954 | +152.0% | 0.00% | – |
Q3 2022 | $57,000 | -54.0% | 36,094 | -41.3% | 0.00% | – |
Q2 2022 | $124,000 | +93.8% | 61,446 | +345.1% | 0.00% | – |
Q4 2021 | $64,000 | -49.2% | 13,805 | -9.6% | 0.00% | -100.0% |
Q1 2021 | $126,000 | -12.5% | 15,266 | -27.8% | 0.00% | 0.0% |
Q4 2020 | $144,000 | -68.3% | 21,130 | -79.5% | 0.00% | -50.0% |
Q3 2018 | $454,000 | – | 103,252 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HUNTINGTON NATIONAL BANK | 15,001 | $1,410 | 0.00% |
KLCM Advisors, Inc. | 20,000 | $1,880 | 0.00% |
AlphaMark Advisors, LLC | 3,135 | $0 | 0.00% |
TRUST CO OF VERMONT | 204 | $19 | 0.00% |
SlateStone Wealth, LLC | 30,866 | $3 | 0.00% |
Coppell Advisory Solutions LLC | 100 | $89 | 0.00% |
Highlander Capital Management, LLC | 1,200 | $0 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
Russell Investments Group, Ltd. | 266 | $25 | 0.00% |
OGOREK ANTHONY JOSEPH /NY/ /ADV | 3,600 | $0 | 0.00% |